USPTO serial 88125441
B
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 22, 2021
- Examiner
- EVANKO, PATRICIA MALESARDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with B?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin S. Costanza
Kevin S. Costanza SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical drugs for treatment of infectious diseases; Chewing gum for medical purposes; ß-blockers; Drugs for medical purposes, namely, valsartan; Antioxidant drugs, namely, antioxidant food supplements; Pre-filled syringes for medical purposes filled with pharmaceutical preparations, namely, pharmaceutical preparations for treating nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Chemical preparations for medical purposes for the treatment of illnesses or conditions, namely, nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Pharmaceutical preparations for the treatment of illnesses or conditions, namely, nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Bostal Drug Delivery Co., Ltd.
- Other trademarks owned by Bostal Drug Delivery Co., Ltd.
- Other trademarks owned by Bostal Drug Delivery Co., Ltd.
- Other trademarks in Class 005
- Similar marks named B
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 22, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 22, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 19, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 21, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 21, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 21, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 17, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 17, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 28, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 28, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 28, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 28, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 28, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 17, 2020 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Feb 17, 2020 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Feb 17, 2020 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 30, 2020 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 17, 2020 | ALIE | ASSIGNED TO LIE | — |
| Jul 1, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 1, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 1, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 21, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 20, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 26, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2018 | NWAP | NEW APPLICATION ENTERED | — |